Zobrazeno 1 - 10
of 472
pro vyhledávání: '"A. DE LÉAN"'
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1982 Mar . 79(6), 1732-1736.
Externí odkaz:
https://www.jstor.org/stable/11871
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1972 Jan 01. 69(1), 283-287.
Externí odkaz:
https://www.jstor.org/stable/61029
Publikováno v:
In Pain 2006 121(1):85-93
Autor:
Fortin, Yann1, De Léan, André1 delean@pharmco.umontreal.ca
Publikováno v:
Canadian Journal of Physiology & Pharmacology. May2006, Vol. 84 Issue 5, p539-546. 8p. 4 Graphs.
Autor:
Ricketts, Ralph E. J., de Léan, Pierre, Wishart, F. O., Gélinas, Georgette P., Champoux, Jeannine, Gareau, Olivette, Kohn, R.
Publikováno v:
Canadian Journal of Public Health / Revue Canadienne de Sante'e Publique, 1966 Oct 01. 57(10), 487-491.
Externí odkaz:
https://www.jstor.org/stable/41983955
Autor:
DE LÉAN, PIERRE
Publikováno v:
Canadian Journal of Public Health / Revue Canadienne de Sante'e Publique, 1967 Jan 01. 58(1), 1-6.
Externí odkaz:
https://www.jstor.org/stable/41984788
Publikováno v:
Molecular Pharmacology. 73:431-440
Natriuretic peptide receptor (NPR) A is composed of an extracellular domain (ECD) with a ligand binding site, a single transmembrane region, a kinase homology domain, and a guanylyl cyclase domain. The natural agonists atrial and brain natriuretic pe
Publikováno v:
Pain. 121:85-93
Anandamide, an endocannabinoid, is degraded by the enzyme fatty acid amide hydrolase which can be inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs). The present work was designed to study the peripheral interactions between anandamide and ib
Publikováno v:
Biochemistry; 20240101, Issue: Preprints